1. Home
  2. OVID vs TSE Comparison

OVID vs TSE Comparison

Compare OVID & TSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • TSE
  • Stock Information
  • Founded
  • OVID 2014
  • TSE 2010
  • Country
  • OVID United States
  • TSE United States
  • Employees
  • OVID N/A
  • TSE N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • TSE Major Chemicals
  • Sector
  • OVID Health Care
  • TSE Industrials
  • Exchange
  • OVID Nasdaq
  • TSE Nasdaq
  • Market Cap
  • OVID 88.9M
  • TSE 91.0M
  • IPO Year
  • OVID 2017
  • TSE 2014
  • Fundamental
  • Price
  • OVID $1.48
  • TSE $1.87
  • Analyst Decision
  • OVID Strong Buy
  • TSE
  • Analyst Count
  • OVID 4
  • TSE 0
  • Target Price
  • OVID $3.13
  • TSE N/A
  • AVG Volume (30 Days)
  • OVID 5.7M
  • TSE 261.8K
  • Earning Date
  • OVID 11-11-2025
  • TSE 11-05-2025
  • Dividend Yield
  • OVID N/A
  • TSE 2.13%
  • EPS Growth
  • OVID N/A
  • TSE N/A
  • EPS
  • OVID N/A
  • TSE N/A
  • Revenue
  • OVID $6,651,000.00
  • TSE $3,258,300,000.00
  • Revenue This Year
  • OVID $1,086.57
  • TSE N/A
  • Revenue Next Year
  • OVID N/A
  • TSE $5.09
  • P/E Ratio
  • OVID N/A
  • TSE N/A
  • Revenue Growth
  • OVID 1070.95
  • TSE N/A
  • 52 Week Low
  • OVID $0.24
  • TSE $1.86
  • 52 Week High
  • OVID $2.01
  • TSE $6.85
  • Technical
  • Relative Strength Index (RSI)
  • OVID 50.82
  • TSE 33.39
  • Support Level
  • OVID $1.53
  • TSE $1.88
  • Resistance Level
  • OVID $1.79
  • TSE $2.12
  • Average True Range (ATR)
  • OVID 0.18
  • TSE 0.14
  • MACD
  • OVID -0.03
  • TSE -0.02
  • Stochastic Oscillator
  • OVID 34.42
  • TSE 2.73

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About TSE Trinseo PLC

Trinseo PLC is a materials company and manufacturer of latex and plastics products. The company's operating segments include Latex Binders, Americas Styrenics, Engineered Materials, and Polymer Solutions. Maximum revenue is generated from its Polymer Solutions segment, which consists of various polymers, the majority of which are for automotive, building, and construction applications. The product offerings of this segment include ABS, styrene-acrylonitrile, polystyrene, and polycarbonate products, which are marketed through brands like Magnum and Styron. Geographically, the company generates maximum revenue from Europe, followed by the United States, Asia-Pacific, and the Rest of the world.

Share on Social Networks: